2022 (v1)
Publication
: Type 2 diabetes mellitus is a recognized risk factor for hepatocellular carcinoma in patients with liver disease, independent from the aetiology of their liver disease. Hence, prevention and treatment of type 2 diabetes mellitus and its underlying cause, insulin resistance, should be considered a treatment-target for patients with liver...
Uploaded on: April 14, 2023